Hi everyone, happy New Year. I'm Sonal. As you may know, we launched a new short form news show last year, 16 minutes, where we cover recent news the A6 and Z podcast way, what's hype, what's real, why they matter from a vantage point in tech, and that show has continued in a separate feed for quite some time now. You can subscribe to it if you haven't already in your podcast app by searching for 16 minutes A6 and Z.

But I'm also sharing the latest episode here in this show feed since we sometimes cover

not just multiple news items, but a single topic prompted by recent headlines like we did

on our episodes on e-sports and the opioid crisis.

This week the topic is personal genomics, the promise, the perils, where are we really

today and where could we be going next? We start with an article by Peter Aldhaus, unquote,

10 years ago, DNA tests were the future of medicine. Now there is social network and a data

privacy mess. The article refers to a series of events, everything from companies like 23

and me and the FDA, to some of the headlines we've seen lately around criminals being caught

based on their relatives' DNA. There's also a number of companies cited in the article who

offer such tests. To be clear, none of the following discussions that should be taken as investment

advice. Please see a6.com slash disclosures for important information.

So that's a context. And super quick summary. Now, let me introduce our A6 and C expert,

general partner Jorge Condé, who has a long history in this area. Since it's a turn of a decade

and the first episode of January, I thought it'd be great for us to do sort of a Janus-themed

look back, look forward, starting with quick reactions

on reading the piece.

Well, when I read the BuzzFeed piece, which was super interesting, it took me back to a very

specific moment in time.

And I was living in this world.

I was in the personal genomic space.

I had just started a startup that was looking to essentially interpret full genome data

...